Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work
Wired

Potential Sciences uses computer-generated biochemical data to train AI models for faster drug development.
Potential Sciences is a startup backed by the UK government aiming to accelerate the drug discovery process. Instead of traditional lab work, the company uses AI models trained on computer-generated biochemical data. This approach seeks to bypass the typically laborious methods of finding new pharmaceutical drugs.
Why it matters: Using AI trained on simulated data could potentially speed up the traditionally laborious process of developing new drugs.

